Sumbare Wellness review

Very few sellers treat a low dose as its own program, and this one does. A named GLP-1 microdose treatment sits in the menu next to semaglutide and tirzepatide, with its own page, described as a gentler protocol aimed at metabolic health, body composition and appetite balance rather than maximum weight loss — which is close to the case this site spends its time making. The pricing structure sounds right alongside it: flat rate, no consultation charge, and explicitly no surcharge when the dose changes. Then the page ends without a number. The microdose program begins with a conversation, neither full-dose page carries a figure either, and the single public price is a banner marked as confirmed only after a provider has reviewed you — which makes it an opening quote rather than a rate anyone can plan around. Nothing is charged if you are not approved, which is a genuine protection and worth having. One more thing belongs in a reader's assessment: the outcome chart on the front page is footnoted to placebo-controlled trials of compounded semaglutide and tirzepatide. Compounded preparations are not what those trials tested, and lending a compounded program that authority is a claim the evidence behind it does not support.

Vs median

Not comparable — no figure is published before intake

Market

$59–$1300/mo is the full published spread in our ranking

Structure

No low-dose price published

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

Sumbare Wellness dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.

Sumbare Wellness is one of the few providers here that treats a low dose as its own program rather than the first rung of a ladder. "GLP-1 Microdose" sits in the menu beside semaglutide and tirzepatide, with its own page, and it is described in almost exactly the terms this site uses: a lower therapeutic dose aimed at metabolic health, body composition and appetite balance rather than maximum weight loss. The pricing structure sounds right too — flat rate, no consultation charge, and explicitly no surcharge when the dose changes. Then the page ends without a number. The microdose program "begins with a conversation", the full-dose pages carry no figure either, and the single public price is a homepage banner marked as confirmed only after a provider has reviewed the patient. So the one question a microdoser arrives with cannot be answered before signing up. One further thing a reader should weigh: the outcome chart on the homepage is sourced to placebo-controlled trials of compounded semaglutide and tirzepatide. Compounded preparations are not what those trials tested — the 24-week evidence comes from the branded products — and borrowing it for a compounded program lends the number an authority it has not earned.

No price is published for the microdose program, or for either full-dose program — it "begins with a conversation".

• The one public figure is annotated "confirmed after provider review", so it is a quote rather than a rate.
• Its homepage outcome chart is footnoted to placebo-controlled trials of compounded formulations; those trials tested the branded products.

Sumbare Wellness is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• What a flat price costs at a low dose
• Titration planner